Sur, S.; Steele, R.; Isbell, T.S.; Venkata, K.N.; Rateb, M.E.; Ray, R.B.
Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling. Cancers 2021, 13, 1432.
https://doi.org/10.3390/cancers13061432
AMA Style
Sur S, Steele R, Isbell TS, Venkata KN, Rateb ME, Ray RB.
Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling. Cancers. 2021; 13(6):1432.
https://doi.org/10.3390/cancers13061432
Chicago/Turabian Style
Sur, Subhayan, Robert Steele, T. Scott Isbell, Kalyan Nagulapalli Venkata, Mostafa E. Rateb, and Ratna B. Ray.
2021. "Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling" Cancers 13, no. 6: 1432.
https://doi.org/10.3390/cancers13061432
APA Style
Sur, S., Steele, R., Isbell, T. S., Venkata, K. N., Rateb, M. E., & Ray, R. B.
(2021). Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling. Cancers, 13(6), 1432.
https://doi.org/10.3390/cancers13061432